$HIMS
Hims & Hers Health, Inc. Stock $hims

$hims Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000177375122000039 Filed on February 24, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$84.70M	$271.9M	$0.00
YoY Change		82.77%
Cost Of Revenue	$22.60M	$67.38M
YoY Change		71.43%
Gross Profit	$62.10M	$204.5M
YoY Change		86.84%
Gross Profit Margin	73.32%	75.22%
Selling, General & Admin	$82.77M	$183.6M	$2.080M
YoY Change	3879.42%	179.91%	766.67%
% of Gross Profit	133.29%	89.8%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.630M	$4.075M
YoY Change		285.53%
% of Gross Profit	2.62%	1.99%
Operating Expenses	$82.77M	$319.5M	$2.080M
YoY Change	3879.42%	156.46%	766.67%
Operating Profit	-$20.67M	-$115.0M
YoY Change		659.65%
Interest Expense	-$9.716M	$0.00	$40.00K
YoY Change	-24390.0%	-100.0%	-95.88%
% of Operating Profit
Other Income/Expense, Net	$33.00K	$4.247M
YoY Change		-249.38%
Pretax Income	-$31.25M	-$110.8M	-$2.040M
YoY Change	1431.76%	515.97%	-379.45%
Income Tax	-$87.00K	-$3.136M
% Of Pretax Income
Net Earnings	-$31.16M	-$107.7M	-$2.040M
YoY Change	1427.5%	494.57%	-379.45%
Net Earnings / Revenue	-36.79%	-39.61%
Basic Earnings Per Share		-$0.58
Diluted Earnings Per Share	-$154.6K	-$0.58	-$81.08K
COMMON SHARES
Basic Shares Outstanding		186.8M shares
Diluted Shares Outstanding		186.8M shares

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$247.3M	$247.3M	$100.2M
YoY Change	146.76%	22379.45%	6580.53%
Cash & Equivalents	$71.78M	$71.78M	$27.34M
Short-Term Investments	$175.5M	$175.5M	$72.86M
Other Short-Term Assets	$890.0K	$5.496M	$1.963M
YoY Change	-54.66%	5396.0%	1863.0%
Inventory	$13.56M	$13.56M	$3.543M
Prepaid Expenses	$4.606M		$2.691M
Receivables	$4.100M	$3.577M	$1.100M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$269.9M	$269.9M	$113.1M
YoY Change	138.68%	24436.82%	6721.16%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.200M	$13.01M	$1.700M
YoY Change	29.41%
Goodwill	$110.9M		$0.00
YoY Change
Intangibles	$25.89M		$59.00K
YoY Change	43781.36%
Long-Term Investments			$204.5M
YoY Change			0.69%
Other Assets	$7.942M	$898.0K	$4.548M
YoY Change	74.63%
Total Long-Term Assets	$150.7M	$150.7M	$5.613M
YoY Change	2584.48%	-26.32%	-97.24%
TOTAL ASSETS
Total Short-Term Assets	$269.9M	$269.9M	$113.1M
Total Long-Term Assets	$150.7M	$150.7M	$5.613M
Total Assets	$420.6M	$420.6M	$118.7M
YoY Change	254.33%	104.56%	-42.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$19.64M	$19.64M	$8.066M
YoY Change	143.49%		43559.0%
Accrued Expenses	$12.19M	$12.61M	$4.984M
YoY Change	144.66%	200.12%	941.42%
Deferred Revenue	$3.188M		$1.272M
YoY Change	150.63%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$79.22M	$79.22M	$15.23M
YoY Change	420.23%	1516.76%	1454.84%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$629.0K	$6.745M	$381.0K
YoY Change	65.09%	-6.32%	-94.71%
Total Long-Term Liabilities	$629.0K	$6.745M	$381.0K
YoY Change	65.09%	-6.32%	-94.71%
TOTAL LIABILITIES
Total Short-Term Liabilities	$79.22M	$79.22M	$15.23M
Total Long-Term Liabilities	$629.0K	$6.745M	$381.0K
Total Liabilities	$85.97M	$85.97M	$15.61M
YoY Change	450.75%	610.46%	90.98%
SHAREHOLDERS EQUITY
Retained Earnings	-$279.0M		-$171.3M
YoY Change	62.85%		-15030.5%
Common Stock	$613.7M		$24.43M
YoY Change	2412.21%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$334.6M	$334.6M	-$146.9M
YoY Change
Total Liabilities & Shareholders Equity	$420.6M	$420.6M	$118.7M
YoY Change	254.33%	104.56%	-42.03%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	-$31.16M	-$107.7M	-$2.040M
YoY Change	1427.5%	494.57%	-379.45%
Depreciation, Depletion And Amortization	$1.630M	$4.075M
YoY Change		285.53%
Cash From Operating Activities	-$3.105M	-$34.40M	-$200.0K
YoY Change	1452.5%	1287.66%	566.67%
INVESTING ACTIVITIES
Capital Expenditures	-$1.486M	-$5.007M
YoY Change
Acquisitions		$46.47M
YoY Change
Other Investing Activities	$11.73M	-$151.3M	$0.00
YoY Change		-45936.67%
Cash From Investing Activities	$10.24M	-$156.3M	$0.00
YoY Change		293.61%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$22.03M
YoY Change
Debt Paid & Issued, Net		$0.00
YoY Change		-100.0%
Cash From Financing Activities	-78.00K	$235.0M	0.000
YoY Change		392.32%	-100.0%
NET CHANGE
Cash From Operating Activities	-3.105M	-$34.40M	-200.0K
Cash From Investing Activities	10.24M	-$156.3M	0.000
Cash From Financing Activities	-78.00K	$235.0M	0.000
Net Change In Cash	7.059M	$44.29M	-200.0K
YoY Change	-3629.5%	697.59%	-25.93%
FREE CASH FLOW
Cash From Operating Activities	-$3.105M	-$34.40M	-$200.0K
Capital Expenditures	-$1.486M	-$5.007M
Free Cash Flow	-$1.619M	-$29.39M
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001773751
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity Registrant Name EntityRegistrantName	HIMS & HERS HEALTH, INC.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity File Number EntityFileNumber	001-38986
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1482650
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	2269 Chestnut Street, #523
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	San Francisco
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94123
CY2021	dei	City Area Code CityAreaCode	415
CY2021	dei	Local Phone Number LocalPhoneNumber	851-0195
CY2021	dei	Security12b Title Security12bTitle	Class A common stock, $0.0001 par value per share
CY2021	dei	Trading Symbol TradingSymbol	HIMS
CY2021	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	false
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	1800000000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	71784000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	25890000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	59000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5111000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27344000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	175490000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	72864000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	13558000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	3543000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9073000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5404000	USD
CY2021Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	0	USD
CY2020Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	3929000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	269905000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	113084000	USD
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	856000	USD
CY2020Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1006000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	110881000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	0	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7942000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4548000	USD
CY2021Q4	us-gaap	Assets Assets	420585000	USD
CY2020Q4	us-gaap	Assets Assets	118697000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	19640000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8066000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	12194000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4984000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3188000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1272000	USD
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	42834000	USD
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	0	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1365000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	USD
CY2021Q4	hims	Warrants And Rights Outstanding Current WarrantsAndRightsOutstandingCurrent	0	USD
CY2020Q4	hims	Warrants And Rights Outstanding Current WarrantsAndRightsOutstandingCurrent	906000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	79221000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	15228000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4117000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	USD
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	1999000	USD
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	0	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	629000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	381000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	85966000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	15609000	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	275000000	shares
CY2020Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	95997674	shares
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2021Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0	shares
CY2020Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	93328118	shares
CY2020Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	93328118	shares
CY2021Q4	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	0	USD
CY2020Q4	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	268452000	USD
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	USD
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	249962000	USD
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	USD
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	249962000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	20000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	5000	USD
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	613687000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	24424000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-137000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-11000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-278951000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	445000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-171292000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	334619000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-146874000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	420585000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	118697000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	271878000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	148757000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	82558000	USD
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	67384000	USD
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	39307000	USD
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	37953000	USD
CY2021	us-gaap	Gross Profit GrossProfit	204494000	USD
CY2020	us-gaap	Gross Profit GrossProfit	109450000	USD
CY2019	us-gaap	Gross Profit GrossProfit	44605000	USD
CY2021	us-gaap	Marketing Expense MarketingExpense	135902000	USD
CY2020	us-gaap	Marketing Expense MarketingExpense	58989000	USD
CY2019	us-gaap	Marketing Expense MarketingExpense	63156000	USD
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	183634000	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	65605000	USD
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	55863000	USD
CY2021	us-gaap	Operating Expenses OperatingExpenses	319536000	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	124594000	USD
CY2019	us-gaap	Operating Expenses OperatingExpenses	119019000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-115042000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-15144000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-74414000	USD
CY2021	hims	Fair Value Adjustment Of Liabilities FairValueAdjustmentOfLiabilities	-3802000	USD
CY2020	hims	Fair Value Adjustment Of Liabilities FairValueAdjustmentOfLiabilities	3101000	USD
CY2019	hims	Fair Value Adjustment Of Liabilities FairValueAdjustmentOfLiabilities	-951000	USD
CY2021	us-gaap	Interest Expense InterestExpense	0	USD
CY2020	us-gaap	Interest Expense InterestExpense	10000	USD
CY2019	us-gaap	Interest Expense InterestExpense	369000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	268000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1858000	USD
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4247000	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2843000	USD
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2440000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-110795000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-17987000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-71974000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3136000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	127000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	90000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-107659000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-18114000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-72064000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-126000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-13000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	4000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-107785000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-18127000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-72060000	USD
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.58
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.58
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.51
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.51
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.07
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.07
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	186781537	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	186781537	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35353809	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	35353809	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34758817	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34758817	shares
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	-71357000	USD
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	23000	USD
CY2019	hims	Adjustments To Additional Paid In Capital Early Exercised Options Vested AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested	12000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	61000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8028000	USD
CY2019	hims	Reclassification Associated With Redemption Of Stock Amount ReclassificationAssociatedWithRedemptionOfStockAmount	4500000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	4000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-72064000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-139793000	USD
CY2020	hims	Stock Exercised During Period Value Common Stock Warrants StockExercisedDuringPeriodValueCommonStockWarrants	561000	USD
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	123000	USD
CY2020	hims	Adjustments To Additional Paid In Capital Early Exercised Options Vested AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested	31000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5831000	USD
CY2020	hims	Expiration Of Redemption Right Value ExpirationOfRedemptionRightValue	4500000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-13000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-18114000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-146874000	USD
CY2021	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	21902000	USD
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	249837000	USD
CY2021	hims	Adjustments To Additional Paid In Capital Related Party Receivable Repayment AdjustmentsToAdditionalPaidInCapitalRelatedPartyReceivableRepayment	854000	USD
CY2021	hims	Adjustments To Additional Paid In Capital Warrant Conversion AdjustmentsToAdditionalPaidInCapitalWarrantConversion	1160000	USD
CY2021	hims	Stock Exercised During Period Value Common Stock Warrants StockExercisedDuringPeriodValueCommonStockWarrants	21679000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	18700000	USD
CY2021	hims	Stock Issued During Period Value Reverse Recapitalization StockIssuedDuringPeriodValueReverseRecapitalization	129659000	USD
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	75000000	USD
CY2021	hims	Adjustments To Additional Paid In Capital Recapitalization Warrant Expense AdjustmentsToAdditionalPaidInCapitalRecapitalizationWarrantExpense	154000	USD
CY2021	hims	Stock Issued During Period Value Contingent Consideration Reverse Recapitalization StockIssuedDuringPeriodValueContingentConsiderationReverseRecapitalization	1000	USD
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	52614000	USD
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1259000	USD
CY2021	hims	Adjustments To Additional Paid In Capital Early Exercised Options Vested AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested	227000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	67767000	USD
CY2021	hims	Share Based Payment Arrangement Payment For Taxes Related To Net Share Settlement Of Equity Awards ShareBasedPaymentArrangementPaymentForTaxesRelatedToNetShareSettlementOfEquityAwards	5998000	USD
CY2021	hims	Stock Issued During Period Value Warrant Redemption StockIssuedDuringPeriodValueWarrantRedemption	16967000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-126000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-107659000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	334619000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-18114000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-107659000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-72064000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4075000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1057000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	260000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	67211000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	5831000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	8028000	USD
CY2021	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	3802000	USD
CY2020	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	-3101000	USD
CY2019	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	951000	USD
CY2021	hims	Noncash Warrant Expense NoncashWarrantExpense	154000	USD
CY2020	hims	Noncash Warrant Expense NoncashWarrantExpense	0	USD
CY2019	hims	Noncash Warrant Expense NoncashWarrantExpense	0	USD
CY2021	hims	Lease Termination Expense Noncash LeaseTerminationExpenseNoncash	0	USD
CY2020	hims	Lease Termination Expense Noncash LeaseTerminationExpenseNoncash	754000	USD
CY2019	hims	Lease Termination Expense Noncash LeaseTerminationExpenseNoncash	0	USD
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	144000	USD
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	322000	USD
CY2019	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	70000	USD
CY2021	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-2166000	USD
CY2020	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-325000	USD
CY2019	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	200000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3388000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2021	hims	Noncash Operating Lease Costs NoncashOperatingLeaseCosts	-1510000	USD
CY2020	hims	Noncash Operating Lease Costs NoncashOperatingLeaseCosts	0	USD
CY2019	hims	Noncash Operating Lease Costs NoncashOperatingLeaseCosts	0	USD
CY2021	us-gaap	Noncash Merger Related Costs NoncashMergerRelatedCosts	1182000	USD
CY2020	us-gaap	Noncash Merger Related Costs NoncashMergerRelatedCosts	0	USD
CY2019	us-gaap	Noncash Merger Related Costs NoncashMergerRelatedCosts	0	USD
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-540000	USD
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-59000	USD
CY2019	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	158000	USD
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	9628000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-674000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	522000	USD
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3200000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	645000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2436000	USD
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	58000	USD
CY2020	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-8000	USD
CY2019	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	755000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	9853000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	826000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-6075000	USD
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	197000	USD
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2423000	USD
CY2019	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-276000	USD
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1412000	USD
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	519000	USD
CY2019	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	212000	USD
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1521000	USD
CY2020	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	0	USD
CY2019	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	0	USD
CY2021	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	0	USD
CY2020	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	381000	USD
CY2019	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-34412000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2479000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-74867000	USD
CY2021	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	266633000	USD
CY2020	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	95008000	USD
CY2019	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	42012000	USD
CY2021	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	158375000	USD
CY2020	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	47990000	USD
CY2019	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	4500000	USD
CY2021	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	3465000	USD
CY2020	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	11550000	USD
CY2019	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	USD
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	46468000	USD
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2019	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2021	us-gaap	Payments For Software PaymentsForSoftware	4175000	USD
CY2020	us-gaap	Payments For Software PaymentsForSoftware	2496000	USD
CY2019	us-gaap	Payments For Software PaymentsForSoftware	1479000	USD
CY2021	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	832000	USD
CY2020	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	1737000	USD
CY2019	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	308000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-156268000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-39299000	USD
CY2021	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	0	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-39701000	USD
CY2020	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	51900000	USD
CY2019	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	102566000	USD
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2019	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	377000	USD
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	22027000	USD
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2021	hims	Proceeds From Issuance Of Common Stock Recapitalization ProceedsFromIssuanceOfCommonStockRecapitalization	197686000	USD
CY2020	hims	Proceeds From Issuance Of Common Stock Recapitalization ProceedsFromIssuanceOfCommonStockRecapitalization	0	USD
CY2019	hims	Proceeds From Issuance Of Common Stock Recapitalization ProceedsFromIssuanceOfCommonStockRecapitalization	0	USD
CY2021	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	75000000	USD
CY2020	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	USD
CY2019	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	USD
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	12851000	USD
CY2020	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	3356000	USD
CY2019	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
CY2021	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	1193000	USD
CY2020	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	0	USD
CY2019	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	0	USD
CY2021	hims	Proceeds From Warrant Exercises Preferred ProceedsFromWarrantExercisesPreferred	0	USD
CY2020	hims	Proceeds From Warrant Exercises Preferred ProceedsFromWarrantExercisesPreferred	29000	USD
CY2019	hims	Proceeds From Warrant Exercises Preferred ProceedsFromWarrantExercisesPreferred	0	USD
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	787000	USD
CY2020	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	561000	USD
CY2019	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2021	hims	Proceeds From Stock Options Exercised Net Of Repurchases ProceedsFromStockOptionsExercisedNetOfRepurchases	1253000	USD
CY2020	hims	Proceeds From Stock Options Exercised Net Of Repurchases ProceedsFromStockOptionsExercisedNetOfRepurchases	123000	USD
CY2019	hims	Proceeds From Stock Options Exercised Net Of Repurchases ProceedsFromStockOptionsExercisedNetOfRepurchases	44000	USD
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2020	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2019	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	2136000	USD
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1515000	USD
CY2019	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	9051000	USD
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	5998000	USD
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2019	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	235043000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	47742000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	95318000	USD
CY2021	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-73000	USD
CY2020	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-9000	USD
CY2019	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-5000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	44290000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	5553000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-18853000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28350000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22797000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	41650000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	72640000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28350000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22797000	USD
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	338000	USD
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	221000	USD
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	139000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	10000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	361000	USD
CY2021	hims	Stock Reclassification Redeemable StockReclassificationRedeemable	0	USD
CY2020	hims	Stock Reclassification Redeemable StockReclassificationRedeemable	0	USD
CY2019	hims	Stock Reclassification Redeemable StockReclassificationRedeemable	4500000	USD
CY2021	hims	Warrants Issued For Debt Issuance Costs WarrantsIssuedForDebtIssuanceCosts	0	USD
CY2020	hims	Warrants Issued For Debt Issuance Costs WarrantsIssuedForDebtIssuanceCosts	0	USD
CY2019	hims	Warrants Issued For Debt Issuance Costs WarrantsIssuedForDebtIssuanceCosts	133000	USD
CY2021	hims	Stock Expired Redemption Right StockExpiredRedemptionRight	0	USD
CY2020	hims	Stock Expired Redemption Right StockExpiredRedemptionRight	4500000	USD
CY2019	hims	Stock Expired Redemption Right StockExpiredRedemptionRight	0	USD
CY2021	hims	Exercise Of Warrants ExerciseOfWarrants	0	USD
CY2020	hims	Exercise Of Warrants ExerciseOfWarrants	11292000	USD
CY2019	hims	Exercise Of Warrants ExerciseOfWarrants	0	USD
CY2021	us-gaap	Recapitalization Costs RecapitalizationCosts	125000	USD
CY2020	us-gaap	Recapitalization Costs RecapitalizationCosts	0	USD
CY2019	us-gaap	Recapitalization Costs RecapitalizationCosts	0	USD
CY2021	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	249837000	USD
CY2020	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	USD
CY2019	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	USD
CY2021	hims	Warrants Assumed WarrantsAssumed	51814000	USD
CY2020	hims	Warrants Assumed WarrantsAssumed	0	USD
CY2019	hims	Warrants Assumed WarrantsAssumed	0	USD
CY2021	hims	Warrants Redeemed And Exercised WarrantsRedeemedAndExercised	37834000	USD
CY2020	hims	Warrants Redeemed And Exercised WarrantsRedeemedAndExercised	0	USD
CY2019	hims	Warrants Redeemed And Exercised WarrantsRedeemedAndExercised	0	USD
CY2021	hims	Conversion Of Preferred Stock Warrants Amount Converted ConversionOfPreferredStockWarrantsAmountConverted	1160000	USD
CY2020	hims	Conversion Of Preferred Stock Warrants Amount Converted ConversionOfPreferredStockWarrantsAmountConverted	0	USD
CY2019	hims	Conversion Of Preferred Stock Warrants Amount Converted ConversionOfPreferredStockWarrantsAmountConverted	0	USD
CY2021	hims	Vesting Of Early Exercised Stock Options Net Of Cancelations VestingOfEarlyExercisedStockOptionsNetOfCancelations	227000	USD
CY2020	hims	Vesting Of Early Exercised Stock Options Net Of Cancelations VestingOfEarlyExercisedStockOptionsNetOfCancelations	31000	USD
CY2019	hims	Vesting Of Early Exercised Stock Options Net Of Cancelations VestingOfEarlyExercisedStockOptionsNetOfCancelations	12000	USD
CY2021	hims	Stock Issued And Contingent Consideration For Business Acquisition StockIssuedAndContingentConsiderationForBusinessAcquisition	99958000	USD
CY2020	hims	Stock Issued And Contingent Consideration For Business Acquisition StockIssuedAndContingentConsiderationForBusinessAcquisition	0	USD
CY2019	hims	Stock Issued And Contingent Consideration For Business Acquisition StockIssuedAndContingentConsiderationForBusinessAcquisition	0	USD
CY2021Q1	hims	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.4530
CY2021	us-gaap	Use Of Estimates UseOfEstimates	The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The more significant estimates and assumptions by management include, among others, valuation of inventory, valuation and recognition of stock-based compensation expense, valuation and recognition of warrants, valuation of contingent consideration in business combinations, purchase price allocation for business combinations, and estimates in capitalization of website development and internal-use software costs. Management believes that the estimates and judgments upon which it relies are reasonable based upon information available to it at the time that these estimates and judgments were made. Actual results experienced by the Company may differ from management’s estimates. To the extent that there are material differences between these estimates and actual results, the Company’s consolidated financial statements will be affected.
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s financial instruments that are potentially exposed to concentrations of credit risk consist primarily of cash and cash equivalents, restricted cash, investments, and accounts receivable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains its cash, cash equivalents, short-term investments, and restricted cash with high-quality financial institutions with investment-grade ratings. The majority of the cash balances are with U.S. banks and are insured to the extent defined by the Federal Deposit Insurance Corporation.</span></div>The prescription products ordered on the Company’s e-commerce online platform are primarily fulfilled by four affiliated and third-party pharmacies. If any of the pharmacies were to stop fulfilling orders, it could significantly slow prescription product sales until fulfillment volume is redistributed to other operating pharmacies. The Company maintains agreements with these pharmacies and is investing in expanding affiliated pharmacy fulfillment capabilities to mitigate any such risk
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	71784000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27344000	USD
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	856000	USD
CY2020Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1006000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	72640000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28350000	USD
CY2020	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	USD
CY2019	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	USD
CY2019	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	USD
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4100000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1100000	USD
CY2020	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2200000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1700000	USD
CY2021Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	5700000	USD
CY2020Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	2800000	USD
CY2021Q4	hims	Capitalized Computer Software Expected Amortization Year One CapitalizedComputerSoftwareExpectedAmortizationYearOne	2457000	USD
CY2021Q4	hims	Capitalized Computer Software Expected Amortization Year Two CapitalizedComputerSoftwareExpectedAmortizationYearTwo	2017000	USD
CY2021Q4	hims	Capitalized Computer Software Expected Amortization Year Three CapitalizedComputerSoftwareExpectedAmortizationYearThree	1253000	USD
CY2021Q4	hims	Capitalized Computer Software Expected Amortization CapitalizedComputerSoftwareExpectedAmortization	5727000	USD
CY2021	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	reporting_unit
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	110900000	USD
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	271878000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	148757000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	82558000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
CY2021	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.50
CY2021	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	3000	USD
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	700000	USD
CY2021	hims	Customer Acquisition Costs CustomerAcquisitionCosts	99100000	USD
CY2020	hims	Customer Acquisition Costs CustomerAcquisitionCosts	44000000	USD
CY2019	hims	Customer Acquisition Costs CustomerAcquisitionCosts	51600000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-107700000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-34400000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-279000000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	71800000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	175500000	USD
CY2021Q1	hims	Reverse Recapitalization Percentage Of Voting Interests Acquired ReverseRecapitalizationPercentageOfVotingInterestsAcquired	1
CY2021Q1	hims	Proceeds From Issuance Of Common Stock Recapitalization ProceedsFromIssuanceOfCommonStockRecapitalization	197700000	USD
CY2021Q1	hims	Reverse Recapitalization Transaction Costs ReverseRecapitalizationTransactionCosts	18700000	USD
CY2021Q1	hims	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.4530
CY2021Q1	hims	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.4530
CY2021Q1	hims	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.4530
CY2021Q1	hims	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.4530
CY2021Q1	hims	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.4530
CY2021Q1	hims	Reverse Recapitalization Contingent Consideration Equity Shares ReverseRecapitalizationContingentConsiderationEquityShares	16000000	shares
CY2021Q1	hims	Reverse Recapitalization Contingent Consideration Equity Earnout Period Stock Price Trigger One ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne	15.00
CY2021Q1	hims	Reverse Recapitalization Contingent Consideration Equity Earnout Period Stock Price Trigger Two ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo	17.50
CY2021Q1	hims	Reverse Recapitalization Contingent Consideration Equity Earnout Period Stock Price Trigger Three ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree	20.00
CY2021Q1	hims	Reverse Recapitalization Contingent Consideration Equity Earnout Period Threshold Trading Days ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays	P10D
CY2021Q1	hims	Reverse Recapitalization Contingent Consideration Equity Earnout Period Threshold Trading Day Period ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDayPeriod	P20D
CY2021Q1	hims	Reverse Recapitalization Contingent Consideration Equity Earnout Period ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriod	P5Y
CY2021Q1	hims	Reverse Recapitalization Contingent Consideration Equity Earnout Period ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriod	P5Y
CY2021	us-gaap	Number Of Businesses Acquired NumberOfBusinessesAcquired	2	acquisition
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	175539000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	49000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	175490000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	72859000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	7000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	72864000	USD
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	10428000	USD
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2856000	USD
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	3130000	USD
CY2020Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	687000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	13558000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	3543000	USD
CY2021Q4	hims	Wholesale Trade Receivables Current WholesaleTradeReceivablesCurrent	3577000	USD
CY2020Q4	hims	Wholesale Trade Receivables Current WholesaleTradeReceivablesCurrent	750000	USD
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	4606000	USD
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2691000	USD
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	890000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1963000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9073000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5404000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	28016000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2126000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	25890000	USD
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2100000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	25890000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	4166000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	3542000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2801000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2672000	USD
CY2021Q4	hims	Finite Lived Intangible Asset Expected Amortization Year Five And Thereafter FiniteLivedIntangibleAssetExpectedAmortizationYearFiveAndThereafter	12709000	USD
CY2021Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	3158000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3363000	USD
CY2020Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	1122000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	919000	USD
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	734000	USD
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1241000	USD
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	954000	USD
CY2020Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	651000	USD
CY2021Q4	hims	Product And Shipping Costs Current ProductAndShippingCostsCurrent	2635000	USD
CY2020Q4	hims	Product And Shipping Costs Current ProductAndShippingCostsCurrent	175000	USD
CY2021Q4	hims	Warrant Exercise Deposit Liability Current WarrantExerciseDepositLiabilityCurrent	0	USD
CY2020Q4	hims	Warrant Exercise Deposit Liability Current WarrantExerciseDepositLiabilityCurrent	664000	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1350000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	212000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	12194000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4984000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	427000	USD
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	1800000	USD
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	300000	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	1521000	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	6756000	USD
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y8M12D
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.040
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1559000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1598000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1638000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1114000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	5909000	USD
CY2021Q1	hims	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.4530
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	5482000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	5500000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1400000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4100000	USD
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	1521000	USD
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	1559000	USD
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	1598000	USD
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	1638000	USD
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	1114000	USD
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	7430000	USD
CY2020	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	2100000	USD
CY2019	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1500000	USD
CY2021Q4	us-gaap	Purchase Obligation PurchaseObligation	2900000	USD
CY2021Q4	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	1800000	USD
CY2021Q4	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	1100000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.51
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.49
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.10
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	12600000	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	700000	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	300000	USD
CY2021Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	10401000	shares
CY2021Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	8974000	shares
CY2020Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	11985000	shares
CY2021Q1	hims	Reverse Recapitalization Contingent Consideration Equity Earnout Period Stock Price Trigger One ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne	15.00
CY2020Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	11393000	shares
CY2021Q1	hims	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.4530
CY2021Q1	hims	Reverse Recapitalization Contingent Consideration Equity Earnout Period Stock Price Trigger Two ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo	17.50
CY2021Q1	hims	Reverse Recapitalization Contingent Consideration Equity Earnout Period Stock Price Trigger Three ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree	20.00
CY2021Q1	hims	Reverse Recapitalization Contingent Consideration Equity Earnout Period Threshold Trading Days ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays	P10D
CY2021Q1	hims	Reverse Recapitalization Contingent Consideration Equity Earnout Period Threshold Consecutive Trading Days ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays	20	day
CY2021Q1	hims	Reverse Recapitalization Contingent Consideration Equity Earnout Period ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriod	P5Y
CY2021Q4	us-gaap	Share Price SharePrice	16.38
CY2021Q1	hims	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.4530
CY2021Q1	hims	Reverse Recapitalization Contingent Consideration Equity Earnout Period Stock Price Trigger One ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne	15.00
CY2021Q1	hims	Reverse Recapitalization Contingent Consideration Equity Earnout Period Stock Price Trigger Two ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo	17.50
CY2021Q1	hims	Reverse Recapitalization Contingent Consideration Equity Earnout Period Stock Price Trigger Three ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree	20.00
CY2021Q1	hims	Reverse Recapitalization Contingent Consideration Equity Earnout Period Threshold Trading Days ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays	P10D
CY2021Q1	hims	Reverse Recapitalization Contingent Consideration Equity Earnout Period Threshold Consecutive Trading Days ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays	20	day
CY2021Q1	hims	Reverse Recapitalization Contingent Consideration Equity Earnout Period ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriod	P5Y
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	67211000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5831000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8028000	USD
CY2021	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	700000	USD
CY2019	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0	USD
CY2020	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0	USD
CY2020Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	95997674	shares
CY2020Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	95997674	shares
CY2020Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	93328118	shares
CY2020Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	93328118	shares
CY2020Q4	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	268452000	USD
CY2020	hims	Proceeds From Issuance Of Temporary Equity ProceedsFromIssuanceOfTemporaryEquity	238641000	USD
CY2021Q1	hims	Recapitalization Exchange Conversion Basis RecapitalizationExchangeConversionBasis	1
CY2021Q1	hims	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.4530
CY2021Q1	hims	Number Of Classes Of Common Stock NumberOfClassesOfCommonStock	2	commonStockClass
CY2021Q1	hims	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.4530
CY2020	us-gaap	Dividends Common Stock DividendsCommonStock	0	USD
CY2019	us-gaap	Dividends Common Stock DividendsCommonStock	0	USD
CY2021	us-gaap	Dividends Common Stock DividendsCommonStock	0	USD
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-109393000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-16934000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-71644000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-1402000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-1053000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-330000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-110795000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-17987000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-71974000	USD
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	252000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	127000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	90000	USD
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	USD
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	252000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	127000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	90000	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-2280000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-966000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-142000	USD
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3388000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3136000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	127000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	90000	USD
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-23267000	USD
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3777000	USD
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-15115000	USD
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-3498000	USD
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-364000	USD
CY2019	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-2690000	USD
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	2018000	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	698000	USD
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	1471000	USD
CY2021	hims	Effective Income Tax Rate Reconciliation Nondeductible Expense Warrant Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseWarrantAmount	-1710000	USD
CY2020	hims	Effective Income Tax Rate Reconciliation Nondeductible Expense Warrant Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseWarrantAmount	-403000	USD
CY2019	hims	Effective Income Tax Rate Reconciliation Nondeductible Expense Warrant Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseWarrantAmount	0	USD
CY2021	hims	Effective Income Tax Rate Reconciliation Nondeductible Expense Officer Compensation Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationAmount	8352000	USD
CY2020	hims	Effective Income Tax Rate Reconciliation Nondeductible Expense Officer Compensation Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationAmount	0	USD
CY2019	hims	Effective Income Tax Rate Reconciliation Nondeductible Expense Officer Compensation Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationAmount	0	USD
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	15971000	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	3948000	USD
CY2019	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	16560000	USD
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-1002000	USD
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	25000	USD
CY2019	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-136000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3136000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	127000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	90000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	61640000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	44342000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	1245000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	68000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	4130000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	732000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	2214000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	211000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	49000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	52000	USD
CY2021Q4	hims	Deferred Tax Assets Contract With Customer Liability DeferredTaxAssetsContractWithCustomerLiability	0	USD
CY2020Q4	hims	Deferred Tax Assets Contract With Customer Liability DeferredTaxAssetsContractWithCustomerLiability	33000	USD
CY2021Q4	hims	Deferred Tax Assets Leasing Arrangements DeferredTaxAssetsLeasingArrangements	1441000	USD
CY2020Q4	hims	Deferred Tax Assets Leasing Arrangements DeferredTaxAssetsLeasingArrangements	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	456000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	378000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	71175000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	45816000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	61328000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	44576000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	9847000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1240000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	6933000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	0	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	2088000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1206000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	1343000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	0	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	112000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	34000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	10476000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1240000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	629000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	USD
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	16800000	USD
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	4100000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	225500000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	180300000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	3700000	USD
CY2021	dei	Auditor Name AuditorName	KPMG LLP
CY2021	dei	Auditor Location AuditorLocation	San Francisco, CA
CY2021	dei	Auditor Firm AuditorFirmId	185

Files In Submission

Name	View Source	Status
0001773751-22-000039-index-headers.html	Edgar Link	pending
0001773751-22-000039-index.html	Edgar Link	pending
0001773751-22-000039.txt	Edgar Link	pending
0001773751-22-000039-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
hims-20211231.htm	Edgar Link	pending
hims-20211231.xsd	Edgar Link	pending
hims-20211231x10kxex1012.htm	Edgar Link	pending
hims-20211231x10kxex109.htm	Edgar Link	pending
hims-20211231x10kxex311.htm	Edgar Link	pending
hims-20211231x10kxex312.htm	Edgar Link	pending
hims-20211231x10kxex321.htm	Edgar Link	pending
hims-20211231x10kxex322.htm	Edgar Link	pending
hims-20211231x10kxexhibit21.htm	Edgar Link	pending
hims-20211231x10kxexhibit23.htm	Edgar Link	pending
hims-20211231x10kxexhibit42.htm	Edgar Link	pending
hims-20211231_cal.xml	Edgar Link	unprocessable
hims-20211231_def.xml	Edgar Link	unprocessable
hims-20211231_g1.jpg	Edgar Link	pending
hims-20211231_htm.xml	Edgar Link	completed
hims-20211231_lab.xml	Edgar Link	unprocessable
hims-20211231_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HIMS
Hims & Hers Health, Inc. Stock $hims

2021 Q4 Form 10-K Financial Statement

#000177375122000039 Filed on February 24, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HIMS Hims & Hers Health, Inc. Stock $hims

2021 Q4 Form 10-K Financial Statement

#000177375122000039 Filed on February 24, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HIMS
Hims & Hers Health, Inc. Stock $hims